Hypertrophic Scarring and Keloids: Pathomechanisms and Current and Emerging Treatment Strategies

被引:1002
作者
Gauglitz, Gerd G. [2 ,3 ]
Korting, Hans C. [2 ]
Pavicic, Tatiana [2 ]
Ruzicka, Thomas [2 ]
Jeschke, Marc G. [1 ,3 ,4 ,5 ]
机构
[1] Sunnybrook Hlth Sci Ctr, Sunnybrook Res Inst, Toronto, ON M4N 3M5, Canada
[2] Ludwig Maximilians Univ Munchen, Dept Dermatol & Allergol, Munich, Germany
[3] Univ Texas Med Branch, Shriners Hosp Children, Dept Surg, Galveston, TX USA
[4] Sunnybrook Hlth Sci Ctr, Ross Tilley Burn Ctr, Toronto, ON M4N 3M5, Canada
[5] Univ Toronto, Dept Surg, Div Plast Surg, Toronto, ON, Canada
关键词
GROWTH-FACTOR-BETA; PULSED-DYE-LASER; IMIQUIMOD 5-PERCENT CREAM; MATRIX-METALLOPROTEINASE; ONION EXTRACT; DOUBLE-BLIND; IN-VITRO; COLLAGENASE PRODUCTION; FIBROBLAST COLLAGEN; MOLECULAR-BASIS;
D O I
10.2119/molmed.2009.00153
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Excessive scars form as a result of aberrations of physiologic wound healing and may arise following any insult to the deep dermis. By causing pain, pruritus and contractures, excessive scarring significantly affects the patient's quality of life, both physically and psychologically. Multiple studies on hypertrophic scar and keloid formation have been conducted for decades and have led to a plethora of therapeutic strategies to prevent or attenuate excessive scar formation. However, most therapeutic approaches remain clinically unsatisfactory, most likely owing to poor understanding of the complex mechanisms underlying the processes of scarring and wound contraction. In this review we summarize the current understanding of the pathophysiology underlying keloid and hypertrophic scar formation and discuss established treatments and novel therapeutic strategies. (c) 2011 The Feinstein Institute for Medical Research, www.feinsteininstitute.org Online address: hftp://www.molmed.org dol: 10.2119/molmed.2009.00153
引用
收藏
页码:113 / 125
页数:13
相关论文
共 141 条
[1]  
Adriessen MP, 1998, J PATHOL, V186, P192, DOI 10.1002/(SICI)1096-9896(1998100)186:2<192::AID-PATH163>3.0.CO
[2]  
2-X
[3]   Keloid pathogenesis and treatment [J].
Al-Attar, A ;
Mess, S ;
Thomassen, JM ;
Kauffman, CL ;
Davison, SP .
PLASTIC AND RECONSTRUCTIVE SURGERY, 2006, 117 (01) :286-300
[4]   Laser scar revision: Comparison study of 585-nm pulsed dye laser with and without intralesional corticosteroids [J].
Alster, T .
DERMATOLOGIC SURGERY, 2003, 29 (01) :25-29
[5]   TREATMENT OF KELOID STERNOTOMY SCARS WITH 585 NM FLASHLAMP-PUMPED PULSED-DYE LASER [J].
ALSTER, TS ;
WILLIAMS, CM .
LANCET, 1995, 345 (8959) :1198-1200
[6]   Laser treatment of hypertrophic scars, keloids, and striae [J].
Alster, TS ;
Handrick, C .
SEMINARS IN CUTANEOUS MEDICINE AND SURGERY, 2000, 19 (04) :287-292
[7]   Treatment of scars: A review [J].
Alster, TS ;
West, TB .
ANNALS OF PLASTIC SURGERY, 1997, 39 (04) :418-432
[8]   PRELIMINARY-RESULTS OF ARGON AND CARBON-DIOXIDE LASER TREATMENT OF KELOID SCARS [J].
APFELBERG, DB ;
MASER, MR ;
LASH, H ;
WHITE, D ;
WESTON, J .
LASERS IN SURGERY AND MEDICINE, 1984, 4 (03) :283-290
[9]  
APIKIAN M, 2004, J DERMATOL, V45, P140
[10]   Cellular and molecular pathology of HTS: basis for treatment [J].
Armour, Alexis ;
Scott, Paul G. ;
Tredget, Edward E. .
WOUND REPAIR AND REGENERATION, 2007, 15 :S6-S17